Latest News

Promising chronic pain drug developed

A recent report indicates that 116-million Americans live with some form of chronic pain. Historically, chemists have developed drugs aimed at just one biological target. Two drugs used together may metabolize differently or present other issues. This new drug, named UMB 425 affects two different opioid receptors, providing diminished tolerance.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • How studying damage to prefrontal lobe has helped unlock the brain's mysteries

  • Breastfeeding study shows need for effective peer counseling programs

  • Socially-assistive robots help kids with autism learn by providing personalized prompts

  • After Great Recession, Americans are unhappy, worried, pessimistic, study finds

  • Cellphone addiction harming academic performance is 'an increasingly realistic possibility'

  • Assortativity signatures of transcription factor networks contribute to robustness

  • Antidepressants show potential for postoperative pain

  • Report advocates improved police training

  • Fear, safety and the role of sleep in human PTSD: Fragmented REM sleep may hinder effective treatment

  • Study reveals drivers of Western consumers' readiness to eat insects

  •